Original Research
Published on 09 Dec 2025
The aryl hydrocarbon receptor is associated with monocytic AML and innate immune resistance reversible with an AHR inhibitor
in Cancer Immunity and Immunotherapy
- 2,148 views
Original Research
Published on 09 Dec 2025
in Cancer Immunity and Immunotherapy
Editorial
Published on 09 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 08 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 08 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 08 Dec 2025
in Microbial Immunology
Review
Published on 08 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 08 Dec 2025
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Published on 08 Dec 2025
in Vaccines and Molecular Therapeutics
Review
Published on 08 Dec 2025
in Cancer Immunity and Immunotherapy
Mini Review
Published on 08 Dec 2025
in Mucosal Immunity
Original Research
Published on 08 Dec 2025
in Immunological Tolerance and Regulation
Editorial
Published on 08 Dec 2025
in Cancer Immunity and Immunotherapy
Editorial
Published on 08 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 08 Dec 2025
in Vaccines and Molecular Therapeutics
Mini Review
Published on 08 Dec 2025
in Vaccines and Molecular Therapeutics
Original Research
Published on 08 Dec 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Published on 08 Dec 2025
in Systems Immunology
Systematic Review
Published on 08 Dec 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Systematic Review
Published on 08 Dec 2025
in Cancer Immunity and Immunotherapy
Review
Published on 08 Dec 2025
in Molecular Innate Immunity
Original Research
Published on 08 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 08 Dec 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Published on 08 Dec 2025
in Vaccines and Molecular Therapeutics
Original Research
Published on 08 Dec 2025
in Multiple Sclerosis and Neuroimmunology